Paul A. Sieving, M.D., Ph.D. is the director of the National Eye Institute (NEI), National Institutes of Health (NIH). He earned his B.A. in physics and history at Valparaiso University. Dr. Sieving obtained his M.D. in 1978 and Ph.D. in bioengineering in 1981 from the University of Illinois. Following medical school he completed his ophthalmology residency at the University of Illinois Eye and Ear Infirmary in Chicago. After the completion of a post-doctoral study on retinal physiology in 1984 at the University of California, San Francisco, Dr. Sieving completed a clinical fellowship in genetic retinal degenerations at Harvard Medical School, Massachusetts Eye and Ear Infirmary. At the University of Michigan Medical School Dr. Sieving was the Paul R. Lichter Professor of Ophthalmic Genetics and founding director of the Center for Retinal and Macular Degeneration in the Department of Ophthalmology and Visual Sciences.
Dr. Sieving is a genetic and medical retina specialist and in 2001 he became an NEI employee. Currently, he is studying inherited retinal and macular degeneration in the laboratory. Dr. Sieving and his laboratory team are investigating drugs to delay degeneration in transgenic and naturally occurring animal models with human eye diseases. In addition to his clinical research, Dr. Sieving sees patients with genetic forms of retinal disease, including retinitis pigmentosa and Stargardt macular degeneration.